Company
United StatesPublic company, NASDAQ: CELUCelularity Inc (NASDAQ: CELU), Florham Park, NJ – FDA Inspections
Inspection records and compliance data for Celularity Inc in Florham Park, New Jersey. 4 FDA inspections on record, 1 Form 483, 1 warning letter, last inspected August 22, 2023. Publicly traded as NASDAQ: CELU.
Company Profile
This profile covers Celularity Inc based in Florham Park, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 0
- NAI
- 3
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 1
First inspected November 2, 2016. Last inspected August 22, 2023.
Most cited issue areas
- Absence of Written Procedures1 inspection
- Expiration date lacking1 inspection
- In-process materials characteristics testing1 inspection
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 22, 2023 | Not classified | Biologics | 1215480 |
| June 21, 2022 | NAI | Biologics · Bioresearch Monitoring | 1173629 |
| April 29, 2019 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 1088848 |
| November 2, 2016 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 992520 |
FDA documents
Form 483s (1)
Warning Letters (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
The Children's Hospital Corporation
Utah Cord Bank LLC
Brooks Life Sciences
Americord Registry LLC
UCSF Medical Center Clinical Laboratories Transfusion Service at Mission Bay
R & B Medical Group Inc.
American Fertility Medical Center - Genetic Infertility & Andrology Laboratory, Inc.
Central California Blood Center
NCH Baker Hospital Downtown
FUJIFILM Wako Chemicals U.S.A. Corporation
Company Information
Name
Celularity Inc
Stock ticker
CELU
Exchange
NASDAQ
Share price
$0.68
Market cap
$22.1M
Price as of
November 13, 2026
FEI Number
3016661001
Address
170 Park Ave, Florham Park, New Jersey 07932, United States
Country
United States
ID: 0a378fd8-7c8c-4c83-8824-31c652745221